Key points are not available for this paper at this time.
High-throughput sequencing can detect minimal residual disease comparable to multiparametric flow cytometry in T-ALL patients.
Share your take
Add a clinician perspective alongside expert commentary.
Wu et al. (Wed,) studied this question.